Kim H, Jeong J, Huh W
Cell Commun Signal. 2025; 23(1):111.
PMID: 40012038
PMC: 11863771.
DOI: 10.1186/s12964-025-02099-x.
Zheng H, Yu J, Gao L, Wang K, Xu Z, Zeng Z
Nat Commun. 2025; 16(1):1826.
PMID: 39979282
PMC: 11842847.
DOI: 10.1038/s41467-025-57124-x.
Wang M, Sang J, Xu F, Wang S, Liu P, Ma J
Adv Sci (Weinh). 2024; 12(4):e2413181.
PMID: 39629989
PMC: 11775548.
DOI: 10.1002/advs.202413181.
Toma A, Shah D, Roth D, Pina J, Hymel L, Turner T
Adv Healthc Mater. 2024; 13(30):e2401480.
PMID: 39388502
PMC: 11616256.
DOI: 10.1002/adhm.202401480.
Glueck M, Lucaciu A, Subburayalu J, Kestner R, Pfeilschifter W, Vutukuri R
Pflugers Arch. 2024; 476(12):1833-1843.
PMID: 39297971
PMC: 11582160.
DOI: 10.1007/s00424-024-03018-8.
Resident memory T cells and cancer.
Gavil N, Cheng K, Masopust D
Immunity. 2024; 57(8):1734-1751.
PMID: 39142275
PMC: 11529779.
DOI: 10.1016/j.immuni.2024.06.017.
Splenocytes and thymocytes migration patterns between lymphoid organs in pregnancy.
Cruz-Cureno G, Rosales-Tarteaut M, Arriaga-Pizano L, Sanchez-Torres L, Castro-Eguiluz D, Prieto-Chavez J
Biochem Biophys Rep. 2024; 39:101769.
PMID: 39050011
PMC: 11268130.
DOI: 10.1016/j.bbrep.2024.101769.
Oral small molecule agents in management of ulcerative colitis: fact or fancy?.
Kasapoglu B, Ertan A
Turk J Med Sci. 2024; 53(6):1526-1536.
PMID: 38813493
PMC: 10762860.
DOI: 10.55730/1300-0144.5722.
Simultaneous deletion of ORMDL1 and ORMDL3 proteins disrupts immune cell homeostasis.
Demkova L, Bugajev V, Adamcova M, Kuchar L, Grusanovic S, Alberich-Jorda M
Front Immunol. 2024; 15:1376629.
PMID: 38715613
PMC: 11074395.
DOI: 10.3389/fimmu.2024.1376629.
Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with Moderately to Severely Active Crohn's Disease.
Harris S, Feagan B, Hanauer S, Vermeire S, Ghosh S, Yan J
Dig Dis Sci. 2024; 69(6):2044-2054.
PMID: 38568396
PMC: 11162376.
DOI: 10.1007/s10620-024-08391-z.
Role of sphingolipids in the host-pathogen interaction.
Matos G, Mota Fernandes C, Del Poeta M
Biochim Biophys Acta Mol Cell Biol Lipids. 2023; 1868(11):159384.
PMID: 37673393
PMC: 11218662.
DOI: 10.1016/j.bbalip.2023.159384.
A Preliminary Study of Pharmacokinetics and Pharmacodynamics of Oral Fingolimod in Dogs.
Yun T, Jeong J, Koo Y, Chae Y, Lee D, Kim H
In Vivo. 2023; 37(5):2128-2133.
PMID: 37652477
PMC: 10500503.
DOI: 10.21873/invivo.13309.
The role of the CD8+ T cell compartment in ageing and neurodegenerative disorders.
Terrabuio E, Zenaro E, Constantin G
Front Immunol. 2023; 14:1233870.
PMID: 37575227
PMC: 10416633.
DOI: 10.3389/fimmu.2023.1233870.
Clinician's Guide to Using Ozanimod for the Treatment of Ulcerative Colitis.
Sands B, Schreiber S, Blumenstein I, Chiorean M, Ungaro R, Rubin D
J Crohns Colitis. 2023; 17(12):2012-2025.
PMID: 37436357
PMC: 10798866.
DOI: 10.1093/ecco-jcc/jjad112.
New tools for immunologists: models of lymph node function from cells to tissues.
Ozulumba T, Montalbine A, Ortiz-Cardenas J, Pompano R
Front Immunol. 2023; 14:1183286.
PMID: 37234163
PMC: 10206051.
DOI: 10.3389/fimmu.2023.1183286.
Lung-resident CD69ST2 T2 cells mediate long-term type 2 memory to inhaled antigen in mice.
Kobayashi T, Iijima K, Matsumoto K, Lama J, Kita H
J Allergy Clin Immunol. 2023; 152(1):167-181.e6.
PMID: 36720287
PMC: 10330297.
DOI: 10.1016/j.jaci.2023.01.016.
Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program.
Feagan B, Schreiber S, Afzali A, Rieder F, Hyams J, Kollengode K
Contemp Clin Trials. 2022; 122:106958.
PMID: 36208720
PMC: 10008122.
DOI: 10.1016/j.cct.2022.106958.
How sphingolipids affect T cells in the resolution of inflammation.
Hartel J, Merz N, Grosch S
Front Pharmacol. 2022; 13:1002915.
PMID: 36176439
PMC: 9513432.
DOI: 10.3389/fphar.2022.1002915.
Recent Advancements in Understanding Primary Cytomegalovirus Infection in a Mouse Model.
Bruce K, Ma J, Lawler C, Xie W, Stevenson P, Farrell H
Viruses. 2022; 14(9).
PMID: 36146741
PMC: 9505653.
DOI: 10.3390/v14091934.
S1P/S1PR1 signaling differentially regulates the allogeneic response of CD4 and CD8 T cells by modulating mitochondrial fission.
Tian L, Wu Y, Choi H, Sui X, Li X, Sofi M
Cell Mol Immunol. 2022; 19(11):1235-1250.
PMID: 36071219
PMC: 9622814.
DOI: 10.1038/s41423-022-00921-x.